Medical Blog About Treatment Abroad

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a highly targeted cancer treatment used for tumors that have spread within the abdominal cavity. Unlike standard chemotherapy, HIPEC delivers heated, high-dose drugs directly into the abdomen after surgical tumor removal – this process allows for stronger local action with fewer...

Cancer remains one of the most complex challenges. If we have a look at numbers, in 2020, approximately 19.3 million new cancer cases emerged worldwide, claiming nearly 10 million lives. By 2022, that figure had climbed to 20 million new diagnoses annually – one in five people will develop cancer during their lifetime.

Endometrial cancer is the most common gynecologic malignancy in Europe. According to the European Cancer Information System (ECIS), supported by the European Network of Cancer Registries (ENCR), there were approximately 125,000 new cases of endometrial cancer diagnosed across Europe in 2022, accounting...

According to GLOBOCAN, head and neck cancers (HNC) were the sixth most common cancer in 2022, with 946,456 new cases. Head and neck cancers comprise a diverse group of malignancies that originate from the upper aerodigestive tract (cancers of the lip, oral cavity, nasal cavity, larynx, nasopharynx, oropharynx...

Neuroendocrine tumors have shown a significant increase in prevalence over the past two decades. Between 2000 and 2018, the age-standardized incidence increased from 4.9 to 8.2 cases per 100,000 population, with the most pronounced increase being among grade 1 tumors, early stages, and appendix neoplasms.

Cervical cancer remains one of the most common gynecological malignancies worldwide, with significant disparities in incidence and survival depending on geography and access to care. According to the World Health Organization, over 600,000 women are diagnosed with cervical cancer each year globally, and...

A cancer diagnosis changes everything. Yet colon cancer – one of the most common malignancies worldwide – has never been more treatable, more understood, or more responsive to innovation than it is today. After treatment for colon cancer stage 1, patients achieve five-year survival rates of 90%, while even advanced cases...

Duodenal cancer is an aggressive malignancy that requires from healthcare professionals expertise beyond standard approaches. According to the statistics, the survival is falling to just 11-19% in advanced cases from 80% in early stages. Traditional duodenum cancer treatment such as Whipple procedure is the approved...